Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.

PloS one - 9 Jul 2009

Fleming Jo Nadine, Shulman Howard M, Nash Richard A, Johnson Pamela Y, Wight Thomas N, Gown Allen, Schwartz Stephen M

Abstract excerpt

BACKGROUND: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus -host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and mat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Disease
Share to Endothelium
Share to Graft vs Host Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Scleroderma, Systemic

Share to Skin Diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 19587802
DOI: 10.1371/journal.pone.0006203
PMCID: PMC2705674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19587802-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.PMID 19587802Read ↗

Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.Semantic proximity Read ↗

Mechanisms of vascular damage in systemic sclerosis.Semantic proximity Read ↗

Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis.Semantic proximity Read ↗

Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.Semantic proximity Read ↗

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis.Semantic proximity Read ↗

Patient-derived vascularized skin organoids unravel the role of systemic sclerosis fibroblasts in microvascular dysfunctionSemantic proximity Read ↗

Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?Semantic proximity Read ↗

Extensive and Persistent Extravascular Dermal Fibrin Deposition Characterizes Systemic SclerosisSemantic proximity Read ↗

The Role of Vascular Endothelial Growth Factor in Systemic SclerosisSemantic proximity Read ↗

Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis.Semantic proximity Read ↗

Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.Semantic proximity Read ↗

Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.